期刊文献+

体重指数与胰岛素抵抗及血脂异常的关系(附260例报告) 被引量:4

下载PDF
导出
摘要 根据体重指数将 2 60例 2型糖尿病患者分为 3组 ,观察与胰岛素作用指数及血脂异常之间的关系。结果发现 :体重指数正常组 ,胰岛素作用指数及血脂在正常范围。而超重和肥胖组 ,胰岛素作用指数下降 ,甘油三酯和胆固醇增高 ,高密度脂蛋白下降。体重指数越高 ,后者改变越明显。说明肥胖与胰岛素抵抗及脂代谢紊乱密切相关。
作者 张兆鹏 刘娜
出处 《辽宁实用糖尿病杂志》 2001年第4期17-18,共2页 Liaoning Journal of Practical Diabetology
  • 相关文献

参考文献3

二级参考文献16

  • 1Nina M, Bella K, Etty I, et al. Sensitization to Insulin Induced by β. β′ - methyl - Substituted Hexadecanedioic Acid(MEDICA16) in Obese Zucker Rats in Vivo. Diabetes 1997,46:1958.
  • 2Ueda H, Kegami H, Kawagnchiy et al. Inhertance of Diabetes in a New Mouse Model of NIDDM, the NSY Mouse. Diabetologia 1997, 40: 671.
  • 3George A, Angela MB, Steven MW, et al. Effects of Mutation in the Human Uncoupling Protein 3 Gene on the Respirator Quotient and Fat Oxidation in Severe Obesity and Type 2 Diabetes. J Clin Invest 1998, 102(7) :1345.
  • 4Gokgam SH, Peter A, Jose F, et al. Increased Adipose Tissue Expression of Tumor Necrosis Factor - α in Human Obesity and Insulin Resistance. J Clin Invest 1995, 95:2409.
  • 5Dominic JW, Jolio SG, Heather T, et al. Disruption of IRS- 2 Causese Type 2 Diabetes in Mice. Nature 1998, 391 (26):900.
  • 6Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT - induced insulin, glucose,and FFA level. Mol Genet Metab 1998, 63:134.
  • 7Oakes ND, Camilleri SC, Furler SM et al. The insulin sensitizer, BRL49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 1997, 46:935.
  • 8Tang Y, Osawa H, Onuma H et al. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes 1999, 48: 1830.
  • 9Brown KK, Henke BR, Blancbard SG et al,. A novel N -aryl tyrosine activator of peroxisome proliferator - activated receptor - γ revesses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 1999, 48:1415.
  • 10Gregorio F, Ambrosi F, Manfrini S et al. Metformin, plasma glucose and free fatty acids in type Ⅱ diabtic out - patients:results of a clinical study. Diabetes Res Clin Pract 1997, 37 : 21.

共引文献13

同被引文献36

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15722
  • 3张锦.糖尿病脂代谢紊乱的特点及其评价[J].实用糖尿病杂志,1997,5(3):19-19.
  • 4李光伟等.谈中国人肥胖的诊断标准[J].实用糖尿病杂志,2000,8(3):64.
  • 5[7]Bo S, Cavallo - Perin P, Gentile L, et al. Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceriidemia n type 2 diabetic patients. Diabetes Metab 2001 ;27(1): 31 - 35.
  • 6[8]Boden G. Role of fatty aids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997 ;46: 3 - 10.
  • 7[9]Laakso M, Lehto S, Penttila I, et al. Lipids and liporoteins predicting coronary heart disease mortality and morbidity in patients with non - insulin dependent diabetes. Circulation 1993;1421 - 1430.
  • 8[10]Lamarche B, Tchernof A, Manrige P, et al. Fasting insulin and apolipo protein B levels and low - density lipoprotein particle size as risk factors for ischemic heart disease.JAMA 1998 ;279:1955 - 1961.
  • 9[11]Pyorala K, Pederson TR, Kjekshus J, et al. For the Scandinavian Simvastatin Surviral Study: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Slmvastation Survival Study(4S), Diabetes Care 1997;20:614 - 620.
  • 10[12]Grover SA, Coupal L, Zowall H, Dorais. Cost - effectiveness of treating hyperlipidemia in the presence of diabetes: who should be treated? Circulation 2000; 102(7):722 - 727.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部